Manage risk with a simple primary screening test, leading to "early detection."
HIROTSU Bioscience's nematode cancer test, 'N-NOSE,' is a simple, affordable, painless, and highly accurate primary screening test that is expected to enable early detection. It comprehensively checks for cancer risk throughout the entire body.
(This program is designed for those living overseas.)

Manage risk with a simple primary screening test, leading to "early detection."
HIROTSU Bioscience's nematode cancer test, 'N-NOSE,' is a simple, affordable, painless, and highly accurate primary screening test that can help with early detection. It comprehensively checks for cancer risk throughout the entire body.

By lowering the psychological and financial barriers to cancer testing, we aim to alleviate concerns such as, "I'm worried about cancer, but undergoing various tests seems overwhelming." Our goal is to increase awareness of cancer risk management among as many people as possible and provide a starting point for a series of cancer screenings.

(This program is designed for those living overseas.)

Location

〒102-0094
22nd Floor, New Otani Garden Court, 4-1 Kioicho, Chiyoda-ku

Specialty

Primary cancer screening test using nematodes

Available Programs

• Online consultation after the primary cancer screening test "N-NOSE"

  "This is an online consultation program for those who have been determined to be at high risk after the 'N-NOSE' test. A Japanese doctor will conduct the consultation."

  Regarding the Interpretation of N-NOSE® Test Results N-NOSE® assesses cancer risk at the time of testing based on previous clinical research and is not a diagnostic test for cancer. Therefore, even if the test indicates 'no cancer risk detected,' it cannot be conclusively stated that the individual does not have cancer. Similarly, a 'high cancer risk' result does not necessarily mean that the individual has cancer. We advise against making personal decisions based solely on N-NOSE® test results. For the interpretation of the test results and any additional necessary tests, we recommend consulting a physician, taking into account your overall health condition."

  View Details

• The primary cancer screening test "N-NOSE"

  "N-NOSE" is a test that utilizes the keen sense of smell of nematodes, which are attracted to the scent of cancer. This new test, which harnesses the abilities of living organisms, is simple, painless, and has been proven to respond to early-stage cancer. By regularly undergoing this test before any cancer concerns arise, even if cancer is detected, early treatment is possible, reducing both the physical and financial burden.

  "N-NOSE" is a test that utilizes the keen sense of smell of nematodes, which are attracted to the scent of cancer. This innovative test, harnessing the abilities of living organisms, is simple, painless, and has been proven to respond to early-stage cancer. By regularly undergoing this test before any cancer concerns arise, even if cancer is detected, early treatment is possible, reducing both the physical and financial burden. This test can determine the risk of cancer throughout the body with high accuracy from just a single drop of urine. - **Simplicity:** Like a health check-up, the test can be performed with a small amount of urine. - **High Accuracy:** The sensitivity is 86.3%. - **Early Detection:** Clinical studies have confirmed that it can detect early-stage cancers (Stage 0 and I). - **No Pain:** There is no physical burden since the test requires only a single drop of urine. - **Comprehensive:** A single test can assess the risk of cancer throughout the body. - As of September 2019, 15 types of cancer are known to trigger a response from nematodes: stomach, colon, lung, breast, pancreas, liver, prostate, uterus, esophagus, gallbladder, bile duct, kidney, bladder, ovary, and oral/pharyngeal cancers.

  View Details